Treatment of pancreatic cancer using an oncolytic virus harboring the lipocalin-2 gene (Q45358201)

13 December 2017

Treatment of pancreatic cancer using an oncolytic virus harboring the lipocalin-2 gene (English)

1 reference

13 December 2017

1 reference

1 reference

Bin Xu

1

1 reference

13 December 2017

Wen-Yan Zheng

2

1 reference

13 December 2017

Da-Yong Jin

3

1 reference

13 December 2017

Dan-Song Wang

4

1 reference

13 December 2017

Xin-Yuan Liu

5

1 reference

13 December 2017

Xin-Yu Qin

6

1 reference

13 December 2017

language of work or name

English

0 references

publication date

19 April 2012

1 reference

13 December 2017

1 reference

13 December 2017

118

1 reference

13 December 2017

21

1 reference

13 December 2017

5217-5226

1 reference

13 December 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Outcomes in pancreatic cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Verapamil enhances the antitumoral efficacy of oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Combination of conditionally replicative adenovirus and standard chemotherapies shows synergistic antitumor effect in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Targeting gene-virotherapy of cancer and its prosperity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Apoptosis induced by uterine 24p3 protein in endometrial carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Identification of 24p3 as a direct target of Foxo3a regulated by interleukin-3 through the phosphoinositide 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Early modulation of gene expression used as a biomarker for chemoprevention in a preclinical model of colon carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Oncolytic parvoviruses as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

New perspectives in cancer virotherapy: bringing the immune system into play

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Oncolytic virotherapy of gynecologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

E1B-55kD-deleted oncolytic adenovirus armed with canstatin gene yields an enhanced anti-tumor efficacy on pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Optimization of conditionally replicative adenovirus for pancreatic cancer and its evaluation in an orthotopic murine xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Effects of tumor selective replication-competent herpes viruses in combination with gemcitabine on pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Phenotype and genotype of pancreatic cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Hyperstable U1snRNA complementary to the K-ras transcripts induces cell death in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Impact of intraoperative neurophysiological monitoring on surgery of high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Independent association of extent of resection with survival in patients with malignant brain astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Lipocalin 2: a multifaceted modulator of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Lipocalin-2: pro- or anti-apoptotic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27535

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.27535

1 reference

13 December 2017

1 reference